Bruce & Co
Latest statistics and disclosures from Bruce & Co's latest quarterly 13F-HR filing:
- Top 5 stock holdings are UHAL.B, Merck & Co, ABBV, ALL, DUK, and represent 42.74% of Bruce & Co's stock portfolio.
- Added to shares of these 4 stocks: BG (+$5.1M), ADM, VICR, DAR.
- Started 2 new stock positions in ADM, BG.
- Reduced shares in these 3 stocks: XEL (-$5.4M), UHAL.B, KOD.
- Bruce & Co was a net buyer of stock by $800k.
- Bruce & Co has $302M in assets under management (AUM), dropping by 5.20%.
- Central Index Key (CIK): 0001358331
Tip: Access up to 7 years of quarterly data
Positions held by Bruce & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Bruce & Co
Bruce & Co holds 39 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Uhaul B Common (UHAL.B) | 10.9 | $33M | -8% | 493k | 66.68 |
|
| Merck Common | 9.7 | $29M | 221k | 131.95 |
|
|
| Abbvie Common (ABBV) | 8.3 | $25M | 138k | 182.10 |
|
|
| Allstate Common (ALL) | 7.3 | $22M | 127k | 173.01 |
|
|
| Duke Energy Common (DUK) | 6.5 | $20M | 204k | 96.71 |
|
|
| CMS Energy Common (CMS) | 6.3 | $19M | 316k | 60.34 |
|
|
| Nextera Energy Common | 6.2 | $19M | 294k | 63.91 |
|
|
| Abbott Common (ABT) | 5.7 | $17M | 150k | 113.66 |
|
|
| At & T Common (T) | 5.6 | $17M | 961k | 17.60 |
|
|
| Insteel Common (IIIN) | 4.4 | $13M | 343k | 38.22 |
|
|
| XEL Energy Common (XEL) | 3.4 | $10M | -34% | 193k | 53.75 |
|
| Pfizer Common (PFE) | 2.5 | $7.5M | 269k | 27.75 |
|
|
| Avista Common (AVA) | 2.3 | $7.1M | 202k | 35.02 |
|
|
| Darling Ingredients Common (DAR) | 2.3 | $7.0M | +7% | 150k | 46.51 |
|
| Bausch Health Common | 2.3 | $6.8M | 644k | 10.61 |
|
|
| Apple Common (AAPL) | 2.0 | $6.0M | 35k | 171.48 |
|
|
| Bunge Common (BG) | 1.7 | $5.1M | NEW | 50k | 102.52 |
|
| Uhaul Common (UHAL) | 1.6 | $4.8M | 71k | 67.54 |
|
|
| Edap Common (EDAP) | 1.3 | $4.1M | 554k | 7.35 |
|
|
| Archer Daniels Common (ADM) | 1.0 | $3.1M | NEW | 50k | 62.81 |
|
| Acorda Theraputics Cv 6.0% (Principal) | 0.9 | $2.9M | 5.0M | 0.57 |
|
|
| Supernus Common (SUPN) | 0.9 | $2.8M | 82k | 34.11 |
|
|
| Lava Theraputics Common (LVTX) | 0.9 | $2.6M | 772k | 3.33 |
|
|
| Newmont Common (NEM) | 0.8 | $2.4M | 66k | 35.84 |
|
|
| Kodiak Sciences Common (KOD) | 0.7 | $2.2M | -10% | 423k | 5.26 |
|
| XM Sirius Common (SIRI) | 0.7 | $2.2M | 558k | 3.88 |
|
|
| Vicor Common (VICR) | 0.6 | $1.7M | +50% | 45k | 38.24 |
|
| Accelerate Diagnostic Cv 5.0% (Principal) | 0.5 | $1.5M | 3.1M | 0.48 |
|
|
| Ashland Common | 0.5 | $1.5M | 15k | 97.37 |
|
|
| Fate Theraputics Common (FATE) | 0.3 | $1.0M | 143k | 7.34 |
|
|
| Caribu Biosciences Common (CRBU) | 0.3 | $1.0M | 200k | 5.14 |
|
|
| Mannkind Common (MNKD) | 0.3 | $884k | 195k | 4.53 |
|
|
| Viatris Common (VTRS) | 0.2 | $696k | 58k | 11.94 |
|
|
| IGM Bioscience Common (IGMS) | 0.2 | $627k | 65k | 9.65 |
|
|
| Organon Common (OGN) | 0.2 | $586k | 31k | 18.80 |
|
|
| 908 Devices Common (MASS) | 0.2 | $516k | 68k | 7.55 |
|
|
| Personalis Common (PSNL) | 0.1 | $447k | 300k | 1.49 |
|
|
| Rli Common (RLI) | 0.1 | $297k | 2.0k | 148.47 |
|
|
| Warner Bros. Discovery Common (WBD) | 0.0 | $93k | 11k | 8.73 |
|
Past Filings by Bruce & Co
SEC 13F filings are viewable for Bruce & Co going back to 2010
- Bruce & Co 2024 Q1 filed May 13, 2024
- Bruce & Co 2023 Q4 filed Feb. 12, 2024
- Bruce & Co 2023 Q3 filed Nov. 13, 2023
- Bruce & Co 2023 Q2 filed Aug. 8, 2023
- Bruce & Co 2023 Q1 filed May 12, 2023
- Bruce & Co 2022 Q4 filed Feb. 15, 2023
- Bruce & Co 2022 Q3 filed Nov. 15, 2022
- Bruce & Co 2022 Q2 filed Aug. 9, 2022
- Bruce & Co 2022 Q1 filed May 11, 2022
- Bruce & Co 2021 Q4 filed Feb. 16, 2022
- Bruce & Co 2021 Q3 filed Nov. 12, 2021
- Bruce & Co 2021 Q2 filed Aug. 16, 2021
- Bruce & Co 2021 Q1 filed May 17, 2021
- Bruce & Co 2020 Q4 filed Feb. 16, 2021
- Bruce & Co 2020 Q3 filed Nov. 13, 2020
- Bruce & Co 2020 Q2 filed Aug. 14, 2020